Skip to content
Alan W. Katz, M.D., M.P.H.

Alan W. Katz, M.D., M.P.H.

Radiation Oncology, Cancer

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Not Accepting New Patients

About Me

I was drawn to gastrointestinal oncology because it is a challenging field, which includes some of the most lethal cancers. Radiation therapy plays an important role in the management of these diverse malignancies, including its use prior to surgery, as definitive treatment with chemotherapy and for...
I was drawn to gastrointestinal oncology because it is a challenging field, which includes some of the most lethal cancers. Radiation therapy plays an important role in the management of these diverse malignancies, including its use prior to surgery, as definitive treatment with chemotherapy and for palliation of local or metastatic disease. I also have expertise in stereotactic body radiation therapy for the treatment of primary and metastatic gastrointestinal malignancies.

My philosophy of patient care is based on a personalized approach, providing each patient with comprehensive information regarding his or her diagnosis, treatment options and prognosis. It is a privilege to be entrusted with a patient's care – and I will always do my best to treat my patients with integrity, compassion and respect.

Conditions I Treat

- Esophageal cancer
- Pancreatic cancer
- Liver cancer
- Rectal cancer
- Anal cancer
- Other gastrointestinal malignancies

Credentials

Residency & Fellowship

Fellowship, Radiation Oncology, University of Rochester School of Medicine GME. 1991 - 1992

Residency, Chaim Sheba Medical Center (Israel). 1986 - 1993

Internship, Assaf Nasofeh Medical Center. 1985 - 1986

Education

MD | Sackler School of Medicine (Tel Aviv University). 1985

Awards

Physician's Recognition Award. 2011 - 2014

Casarett Award. 2005

Publications

Journal Articles

Long-term outcomes of NRG Oncology/RTOG 0529: a Phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in anal canal cancer

Kachnic LA; Winter KA; Myerson RJ; Goodyear MD; Abitbol AA; Streeter OE; Augspurger ME; Schefter TE; Katz AW; Fisher BJ; Henke LE; Narayan S; Crane CH.

Int J Radiat Oncol Biol Phys. 2022; 112(1): 146-157.

Modulation of the human pancreatic ductal adenocarcinoma immune microenvironment by stereotactic body radiotherapy

Mills BN; Qiu H; Drage MG; Chen C; Mathew JS; Garrett-Larsen J; Ye J; Uccello TP; Murphy JD; Belt BA; Lord EM; Katz AW; Linehan DC; Gerber SA.

Clin Cancer Res. 2022; 28(1): 150-162.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial

Safran HP; Winter K; Ilson DH; Wigle D; DiPetrillo T; Haddock MG; Hong TS; Leichman LP; Rajdev L; Resnick M; Kachnic LA; Seaward S; Mamon H; Diaz Pardo DA; Anderson CM; Shen X; Sharma AK; Katz AW; Salo J; Leonard KL; Moughan J; Crane CH.

Lancet Oncol. 2022; 23(2): 259-269.

Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question-erlotinib+gemcitabine for resected cancer of the pancreatic head: a phase II randomized clinical trial

Abrams RA; Winter KA; Safran H; Goodman KA; Regine WF; Berger AC; Gillin MT; Philip PA; Lowy AM; Wu A; DiPetrillo TA; Corn BW; Seaward SA; Haddock MG; Song S; Jiang Y; Fisher BJ; Katz AW; Mehta S; Willett CG; Crane CH.

Am J Clin Oncol. 2020; 43: 173-179.

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

Cummings MA, Usuki KY, Fleming FJ, Tejani MA, Katz AW

Journal of gastrointestinal oncology.. 2019 April 10 (2):357-361. Epub 1900 01 01.

Stereotactic body radiation therapy versus metastasectomy for oligometastases.

Qiu H, Katz AW, Milano MT

Journal of thoracic disease.. 2019 April 11 (4):1082-1084. Epub 1900 01 01.

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.

Milano MT, Katz AW, Zhang H, Huggins CF, Aujla KS, Okunieff P

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2019 February 131 :45-51. Epub 12/28/2018.

NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases

Dawson LA; Winter KA; Katz AW; Schell MC; Brierley J; Chen Y; Kopek N; Crane CH; Willett CG.

Pract Radiat Oncol. 2019; 9(4): e386-e393.

Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review

Clyde JW; Katz AW.

Case Rep Oncol. 2019; 12: 807-813.

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years.

Aujla KS, Katz AW, Singh DP, Okunieff P, Milano MT

Frontiers in oncology.. 2019 9 :111. Epub 02/27/2019.

SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center.

Qiu H, Moravan MJ, Milano MT, Usuki KY, Katz AW

Journal of gastrointestinal cancer.. 2018 December 49 (4):463-469. Epub 1900 01 01.

Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.

Bates JE, Choi G, Usuki KY, Katz AW, Milano MT

American journal of clinical oncology.. 2018 December 41 (12):1172-1175. Epub 1900 01 01.

Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012.

Becerra AZ, Probst CP, Fleming FJ, Xu Z, Aquina CT, Justiniano CF, Boodry CI, Swanger AA, Noyes K, Katz AW, Monson JR, Jusko TA

The American journal of hospice & palliative care.. 2018 February 35 (2):336-342. Epub 05/11/2017.

Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.

Qiu H, Katz AW, Chowdhry AK, Usuki KY, Singh DP, Metcalfe S, Cheruvu P, Chen Y, Okunieff P, Milano MT

American journal of clinical oncology.. 2018 January 41 (1):53-58. Epub 1900 01 01.

Oligometastases to the liver: predicting outcomes based upon radiation sensitivity.

Qiu H, Katz AW, Milano MT

Journal of thoracic disease.. 2016 October 8 (10):E1384-E1386. Epub 1900 01 01.

Comparison of outcomes between SBRT, yttrium-90 radioembolization, trans-arterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma

Mohamed M; Katz AW; Tejani M; Sharma AK; Kashyap R; Noel MS; Qiu H; Hezel AF; Ramaraju GA; Dokus MK; Orloff MS.

Adv Radiat Oncol. 2016; 1(1): 35-42.

Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature.

Chawla S, Katz AW, Rauh SM, Monson JR

American journal of clinical oncology.. 2015 October 38 (5):534-40. Epub 1900 01 01.

Long-Term Survival of a Patient with Metastatic Small-Cell Carcinoma of the Stomach Treated with Radiation Therapy.

Bergsma DP, Schoeniger LO, Bratton L, Katz AW

Case reports in oncology.. 2015 8 (3):416-22. Epub 10/08/2015.

Supraumbilical rash caused by nontarget radioembolization to the falciform artery.

Sharma AK, Foster TH, Katz A, Lee DE, Waldman DL

Journal of vascular and interventional radiology : JVIR.. 2014 March 25 (3):483-4. Epub 1900 01 01.

Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.

Mondo EL, Noel MS, Katz AW, Schoeniger LO, Hezel AF

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 January 2031 (3):e37-9. Epub 12/10/2012.

Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients

Ryan JL; Heckler CE; Ling M; Katz A; Williams JP; Pentland AP; Morrow GR.

Radiat Res. 2013; 180: 34-43.

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

Milano MT, Katz AW, Zhang H, Okunieff P

International journal of radiation oncology, biology, physics.. 2012 July 183 (3):878-86. Epub 12/13/2011.

Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.

Katz AW, Chawla S, Qu Z, Kashyap R, Milano MT, Hezel AF

International journal of radiation oncology, biology, physics.. 2012 July 183 (3):895-900. Epub 12/13/2011.

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.

Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, Aucejo F, Miller C, Fung J, Lo S, Machtay M, Sanabria JR

Acta oncologica.. 2012 May 51 (5):575-83. Epub 01/23/2012.

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.

Janelsins MC, Mustian KM, Palesh OG, Mohile SG, Peppone LJ, Sprod LK, Heckler CE, Roscoe JA, Katz AW, Williams JP, Morrow GR

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2012 April 20 (4):831-9. Epub 05/01/2011.

Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.

Fuller CD, Nijkamp J, Duppen JC, Rasch CR, Thomas CR, Wang SJ, Okunieff P, Jones WE, Baseman D, Patel S, Demandante CG, Harris AM, Smith BD, Katz AW, McGann C, Harper JL, Chang DT, Smalley S, Marshall DT, Goodman KA, Papanikolaou N, Kachnic LA,

International journal of radiation oncology, biology, physics.. 2011 February 179 (2):481-9. Epub 04/18/2010.

Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ.

Milano MT, Katz AW, Okunieff P

American journal of clinical oncology.. 2010 April 33 (2):157-63. Epub 1900 01 01.

Stereotactic body radiotherapy for treatment of adrenal metastases.

Chawla S, Chen Y, Katz AW, Muhs AG, Philip A, Okunieff P, Milano MT

International journal of radiation oncology, biology, physics.. 2009 September 175 (1):71-5. Epub 02/26/2009.

Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy.

Milano MT, Chen Y, Katz AW, Philip A, Schell MC, Okunieff P

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.. 2009 June 91 (3):301-6. Epub 03/28/2009.

Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.

Milano MT, Katz AW, Schell MC, Philip A, Okunieff P

International journal of radiation oncology, biology, physics.. 2008 December 172 (5):1516-22. Epub 05/19/2008.

A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.

Milano MT, Katz AW, Muhs AG, Philip A, Buchholz DJ, Schell MC, Okunieff P

Cancer.. 2008 February 1112 (3):650-8. Epub 1900 01 01.

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.

Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P

International journal of radiation oncology, biology, physics.. 2007 March 167 (3):793-8. Epub 12/29/2006.

Solitary metastases: illusion versus reality.

Rubin P, Brasacchio R, Katz A

Seminars in radiation oncology.. 2006 April 16 (2):120-30. Epub 1900 01 01.

Sampson, M.C.; Katz, A.; Constine, L.S.

Stereotactic body radiation therapy for extracranial

Stereotactic Body Radiation Therapy (SBRT) for lung metastases.

Okunieff P, Petersen AL, Philip A, Milano MT, Katz AW, Boros L, Schell MC

Acta oncologica.. 2006 45 (7):808-17. Epub 1900 01 01.

High dose rate brachytherapy for nonmalignant airway obstruction: new treatment option.

Brenner B, Kramer MR, Katz A, Feinmesser R, Weissmann-Brenner A, Sulkes A, Fenig E, Brenner-Weissman A

Chest.. 2003 October 124 (4):1605-10. Epub 1900 01 01.

Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction.

Kramer MR, Katz A, Yarmolovsky A, Schifter D, Fenig E

Thorax.. 2001 May 56 (5):415-6. Epub 1900 01 01.

Second neoplasms in patients with Merkel cell carcinoma.

Brenner B, Sulkes A, Rakowsky E, Feinmesser M, Yukelson A, Bar-Haim E, Katz A, Idelevich E, Neuman A, Barhana M, Fenig E

Cancer.. 2001 April 191 (7):1358-62. Epub 1900 01 01.

Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.

Fenig E, Brenner B, Katz A, Sulkes J, Lapidot M, Schachter J, Malik H, Sulkes A, Gutman H

Oncology reports.. 2001 8 (2):305-9. Epub 1900 01 01.

Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer.

Katz A, Njuguna E, Rakowsky E, Sulkes A, Sulkes J, Fenig E

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.. 2001 11 (3):234-5. Epub 1900 01 01.

Umbilical metastases of gallbladder carcinoma unrelated to a laparoscopic procedure.

Figer A, Brenner B, Katz A, Njuguna E, Sulkes A

Digestive diseases and sciences.. 2000 June 45 (6):1058-60. Epub 1900 01 01.

[Breast cancer after mantle field irradiation for Hodgkin's disease].

Katz A, Brenner B, Sulkes A, Luria H, Marshak G, Fenig E

Harefuah.. 2000 May 15138 (10):823-5, 911. Epub 1900 01 01.

[High dose endobronchial brachytherapy for malignant airway obstruction: first study of 30 patients].

Yarmolovsky A, Katz A, Fenig E, Fink G, Bendayan D, Sulkes A, Kramer MR

Harefuah.. 2000 March 15138 (6):429-31, 520. Epub 1900 01 01.

Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide.

Fenig E, Brenner B, Njuguna E, Katz A, Schachter J, Sulkes A

American journal of clinical oncology.. 2000 February 23 (1):65-7. Epub 1900 01 01.

[Dose-intensive chemotherapy with continuous infusion 5-fluorouracil].

Tichler T, Ghodsizade E, Katz A, Rath P, Berger R, Brenner H

Harefuah.. 1999 November 1137 (9):387-90, 430. Epub 1900 01 01.

Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines.

Brenner B, Rakowsky E, Katz A, Gutman H, Sulkes A, Schacter J, Fenig E

International journal of oncology.. 1999 June 14 (6):1097-102. Epub 1900 01 01.

Role of radiation therapy in the management of cutaneous malignant melanoma.

Fenig E, Eidelevich E, Njuguna E, Katz A, Gutman H, Sulkes A, Schechter J

American journal of clinical oncology.. 1999 April 22 (2):184-6. Epub 1900 01 01.

Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel.

Fenig E, Brenner B, Rakowsky E, Lapidoth M, Katz A, Sulkes A

American journal of clinical oncology.. 1998 October 21 (5):498-500. Epub 1900 01 01.

The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma.

Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A

Cancer.. 1997 September 180 (5):881-5. Epub 1900 01 01.

Merkel cell carcinoma in Israel.

Brenner B, Katz A, Rakowski E, Feinmesser M, Bar Hanna M, Sulkes A, Fenig E

Israel journal of medical sciences.. 1996 December 32 (12):1235-8. Epub 1900 01 01.

Books

ALERT: Adverse Late Effects of Cancer Treatment (2013)

Chapter: The Testes

Authors: Ginsberg JP; Katz AW

Publisher: Springer, New York 2013

Stereotactic Body Radiation Therapy (2012)

Chapter: Liver metastasis

Authors: Stinauer M; Lanciano R; Schefter TE; Kavanagh B; Carlson JA; Katz AW

Publisher: Springer, Heidelberg 2012

Image Guided Radiation Therapy: A Clinical Perspective (2011)

Chapter: KV planar image-guided SBRT using the Novalis system in an ovarian cancer patient with liver metastases

Authors: Katz AW; Cheruvu P; Schell MC; Phillip A; Milano MT

Publisher: People's Medical Publishing House-USA, Shelton, CT 2011